Government Regulation Of Drug Prices In China

Health services is directly related to people's health and quality of life, involving almost every family and every person's best interests. Value of human life, health value more and more to be respected, focusing on livelihood issues have become the central task of government. Highlight the status of health system reform, drug distribution system, especially the price of drugs as one of the key links, it is of concern to all parties.In this paper, the field of pharmaceutical distribution in China government regulation of drug prices as the research object to the special nature of medicines as a starting point, issues of government regulation of drug prices theoretical analysis, conducted on the basis of government regulation of drug prices for the specific research question. First, review the history of the process of drug distribution system to observe the performance of previous reforms have produced. Secondly, the focus of our current drug distribution system, government regulation of drug prices under the main problems that exist. Delayed because of medical and health system reform, medical institutions chasing profits of drug sales arrangements and interests of institutional mechanism has not yet broken, "to drugs to support medical" problem has not resolved, the field of pharmaceutical distribution troubled government regulation of drug prices, and the absence of government Government hospitals should be the main orientation of the root causes of misconduct. With the problem in a more comprehensive and more profound understanding of, the learning, drawing on the field of pharmaceutical distribution success of government regulation of drug prices, make conform to their national conditions, development of effective government regulation policies, adhere to the role of the government macro-control and service functions, by enhancing the concept of responsibility to raise awareness of regulation; strict pricing mechanism, improve the control of drug prices; enhanced process monitoring, hospital crack monopoly; accelerate health care reform, improve public services and reconstruction of a series of systems of innovation, and improve government regulation of drug prices.